Filing Details
- Accession Number:
- 0001640334-25-000688
- Form Type:
- 13D Filing
- Publication Date:
- 2025-04-24 20:00:00
- Filed By:
- Chinaone Technology Ltd
- Company:
- Yubo International Biotech Ltd
- Filing Date:
- 2025-04-25
- SEC Url:
- 13D Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Chinaone Technology Ltd | 0 | 17,211,400 | 0 | 17,211,400 | 17,211,400 | 14.4% |
| Yang Wang | 17,211,400 | 0 | 17,211,400 | 0 | 17,211,400 | 14.4% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)
|
Yubo International Biotech Ltd (Name of Issuer) |
Class A Common Stock, par value $0.001 per share (Title of Class of Securities) |
988366100 (CUSIP Number) |
Chinaone Technology Limited Wickham's Cay II, P.O. Box 2221, Road Town Tortola, D8, 00000 (86) 136-0129-6655 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
07/15/2024 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 988366100 |
| 1 |
Name of reporting person
Chinaone Technology Ltd | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
VIRGIN ISLANDS, BRITISH
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
17,211,400.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
14.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
OO |
Comment for Type of Reporting Person:
Comment for Percent of class represented by amount in Row (11):
This percentage is based on 119,816,343 shares of Class A Common Stock outstanding as of March 31, 2025, as disclosed in the Issuer's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2025.
SCHEDULE 13D
|
| CUSIP No. | 988366100 |
| 1 |
Name of reporting person
Yang Wang | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
CHINA
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
17,211,400.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
14.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person:
Comments for "Aggregate amount beneficially owned by each reporting person": Represents 17,211,400 shares of Class A Common Stock of the Issuer directly held by Chinaone Technology Limited, an entity 100% owned and controlled by Yang Wang.
Comment for "Percent of class represented by amount in Row (11)": This percentage is based on 119,816,343 shares of Class A Common Stock outstanding as of March 31, 2025, as disclosed in the Issuer's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2025.
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Class A Common Stock, par value $0.001 per share | |
| (b) | Name of Issuer:
Yubo International Biotech Ltd | |
| (c) | Address of Issuer's Principal Executive Offices:
1102, 11th Floor, Building 2, No.10, Chaoyang Park S. Rd., Chaoyang District, Beijing,
CHINA
, 00000. | |
Item 1 Comment:
This Amendment No. 1 (this "Amendment No. 1") to Schedule 13D amends Items 4 and 5 in the Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on January 14, 2021 (the "Original Schedule 13D"), by (i) Chinaone Technology Limited, a company organized under the laws of British Virgin Islands ("Chinaone"), and (ii) Mr. Yang Wang, an individual (together with Chinaone, the "Reporting Persons"), as specifically set forth herein. This Amendment No. 1 is being filed to report a reduction in the aggregate number, and a greater than 1% decrease in the percentage, of shares of Class A Common Stock of the Issuer beneficially owned by the Reporting Persons. Except as otherwise specified in this Amendment No. 1, all other items of the Original Schedule 13D remain unchanged in all material respects. Capitalized terms used but not otherwise defined herein have the respective meanings ascribed to them in the Original Schedule 13D. | ||
| Item 4. | Purpose of Transaction | |
Item 4 of the Original Schedule 13D is hereby supplemented by the addition of the following information:
On July 15, 2024, the Reporting Persons sold 2,000,000 shares of Class A Common Stock at the price of $0.12 per share (the "Transaction"). The Transaction was effectuated in the open market through a broker. The Transaction resulted in a decrease of over 1% in the aggregate percentage ownership reported by the Reporting Persons in the Original Schedule 13D | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | See rows (11) and (13) of the cover pages to this Amendment No. 1 for the aggregate number of shares of Class A Common Stock and percentage of shares of Class A Common Stock beneficially owned by each of the Reporting Persons. | |
| (b) | See rows (7) through (10) of the cover pages to this Amendment No. 1 for the aggregate number of shares of Class A Common Stock and percentage of shares of Class A Common Stock beneficially owned by each of the Reporting Persons. | |
| (c) | The Reporting Persons have not effected any transactions during the past sixty (60) days in any shares of Class A Common Stock. | |
| (d) | Not applicable. | |
| (e) | Not applicable. | |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|